23
Polycystic Ovarian Syndrome Amy Mendez, MPH, RD, LD Registered Dietitian

Polycystic Ovarian Syndrome Amy Mendez, MPH, RD, LD Registered Dietitian

Embed Size (px)

Citation preview

Page 1: Polycystic Ovarian Syndrome Amy Mendez, MPH, RD, LD Registered Dietitian

Polycystic Ovarian Syndrome

Amy Mendez, MPH, RD, LD

Registered Dietitian

Page 2: Polycystic Ovarian Syndrome Amy Mendez, MPH, RD, LD Registered Dietitian

What is PCOS?

• The most common endocrine disorder affecting women of childbearing age

• 5-20% of reproductive age women

Knochenhauer,et al. J Clin Endocrinol Metab. 1998;83;3078-3082.

Page 3: Polycystic Ovarian Syndrome Amy Mendez, MPH, RD, LD Registered Dietitian

Presenting problems

• Oligomenorrhea or Amenorrhea

• Hyperandogenism side effects– Hirsutism– Acne– Male pattern balding

• Infertility

• Obesity/weight gain

Page 5: Polycystic Ovarian Syndrome Amy Mendez, MPH, RD, LD Registered Dietitian

PCOS diagnosis

• 2003 PCOS Consensus Workshop new diagnostic criteria (need at least 2 of 3)– Hyperandrogenism (clinical or serum)

• Ex: testosterone

– Chronic Anovulation (avg menses >45 days)– PCOS ovaries on ultrasound

• Exclude other diseases

Page 6: Polycystic Ovarian Syndrome Amy Mendez, MPH, RD, LD Registered Dietitian

Long term risks of PCOS

• Type 2 DM- 17-45% incidence

• Dyslipidemia

• Endometrial Cancer

• Hypertension -39% incidence

• MI- risk factors predict 7 fold increase

• Gestational DM- 17-38% incidence

• Pregnancy Induced Hypertension- 14% incidence

• Ovarian Cancer

Page 7: Polycystic Ovarian Syndrome Amy Mendez, MPH, RD, LD Registered Dietitian

Hyperandrogenism

Insulin Resistance

Page 8: Polycystic Ovarian Syndrome Amy Mendez, MPH, RD, LD Registered Dietitian

Unlikely that the insulin resistance is a result of the hyperandrogenism

• IR remains after BSO

• Pre-pubertal women with acanthosis nigricans are hyperinsulinemic several years before hyperandrogenism occurs

• Some women with point mutations in the insulin receptor have been shown to have PCOS

• Normal men have androgen concentrations 10-30 fold higher than women, yet they do not demonstrate insulin resistance

Page 9: Polycystic Ovarian Syndrome Amy Mendez, MPH, RD, LD Registered Dietitian

Elevated Insulin levels

• Studies show that women with PCOS have higher insulin levels than obese controls

• Chang et al, 1983 showed that non-obese PCO pts had higher basal and serum insulin levels than controls

Page 10: Polycystic Ovarian Syndrome Amy Mendez, MPH, RD, LD Registered Dietitian

Type 2 Diabetes

Undiagnosed DM IGT

PCOS 7.5% 31.1%

PCOS-non obese 1.5% 10.3%

Age-matched US women 1% 7.8%

Gambineri et al. Diabetes 53(9), 2353-2358.

Page 11: Polycystic Ovarian Syndrome Amy Mendez, MPH, RD, LD Registered Dietitian
Page 12: Polycystic Ovarian Syndrome Amy Mendez, MPH, RD, LD Registered Dietitian

Metabolic Syndrome:

ATP lll Definition Risk Factor Defining Level• Blood pressure 130 or > 85 mm Hg

• Fasting glucose 100 mg/dL

• TG 150 mg/dL

• HDL-C– Men 40 mg/dL– Women 50 mg/dL

• Waist circumference– Men 102 cm (40 in)– Women 88 cm (35 in)

Ford ES et al. JAMA. 2002;287:356-359.

Page 13: Polycystic Ovarian Syndrome Amy Mendez, MPH, RD, LD Registered Dietitian

Therapies for hyperinsulinemia

• Weight loss (obese PCOS)

• Insulin Sensitizers– Troglitozone (Rezulin)– Metformin (Glucophage)– Rosiglitazone (Avandia)– Pioglitazone (Actos)

• Dietary therapies

Page 14: Polycystic Ovarian Syndrome Amy Mendez, MPH, RD, LD Registered Dietitian
Page 15: Polycystic Ovarian Syndrome Amy Mendez, MPH, RD, LD Registered Dietitian

DPP: Benefit of diet + exercise or metformin on diabetes prevention in at-risk patients

Diabetes Prevention Program (DPP) Research Group. N Engl J Med. 2002;346:393-403.

Years

N = 3234 with IFG and IGT, without diabetes

0

0

10

20

30

40

1.0 2.0 3.0 4.0

Placebo

Metformin

Lifestyle

Cumulative

incidence of diabetes

(%)

31%

58%

P*

<0.001

<0.001

*vs placebo

IFG = impaired fasting glucose

Page 16: Polycystic Ovarian Syndrome Amy Mendez, MPH, RD, LD Registered Dietitian

Effect of weight loss

• Diet-induced weight loss of 12.4 kg in 13 obese, insulin-resistant women with PCOS improved: – Fasting insulin – Peak insulin– Insulin AUC– Insulin Sensitivity

Page 17: Polycystic Ovarian Syndrome Amy Mendez, MPH, RD, LD Registered Dietitian

Dietary Composition

• 45 women with PCOS

• Randomized to: – high protein (HP; 40% carb, 30% protein;

n=14)– Low protein (LP; 55% carb, 15% protein; n=14

• 12 weeks energy restriction, 4 wk maintenance

Page 18: Polycystic Ovarian Syndrome Amy Mendez, MPH, RD, LD Registered Dietitian

High Protein vs Low Protein

• Improvements seen for both groups:– Pregnancies– Menstrual cyclicity– Lipid profile– Insulin resistance– Weight– Abdominal fat

• HP group: HDL remained consistent, LP group: HDL dropped during weight loss

Page 19: Polycystic Ovarian Syndrome Amy Mendez, MPH, RD, LD Registered Dietitian

At this time, no clear evidence that diet composition has significant

benefits over the weight loss itself

Page 20: Polycystic Ovarian Syndrome Amy Mendez, MPH, RD, LD Registered Dietitian

Reactive Hypoglycemia

• 64 lean women with PCOS

• 50% prevalence of reactive hypoglycemia– Altuntas, et al. Eur J Obstet Gynecol Reprod Biol 2005

• Would a low glycemic load diet pattern be effective to reduce post-prandial hyperinsulinemia?

• Would this dietary pattern reduce “carbohydrate cravings?”

Page 21: Polycystic Ovarian Syndrome Amy Mendez, MPH, RD, LD Registered Dietitian

Low Glycemic Load Diet

A.M. Herriot et al. J Human Nutr Dietetics 2008

• 88 patients with PCOS referred for nutrition counseling

• Retrospective audit of records at RD and MD visits

•Subjective reports of hunger and carbohydrate cravings improved

Page 22: Polycystic Ovarian Syndrome Amy Mendez, MPH, RD, LD Registered Dietitian

Additional benefits of protective

dietary pattern

Page 23: Polycystic Ovarian Syndrome Amy Mendez, MPH, RD, LD Registered Dietitian

Amy Mendez, MPH, RD, LD

Registered Dietitian

843-876-4795

[email protected]